3.4.3. The Immune Microenvironment: Programmed Death-Ligand 1 (PD-L1) and Other Checkpoint Inhibitors, Tumor-Infiltrating Lymphocytes (TILs), and Innate Lymphoid Cells. This evidence concerns the gene CD274 and neoplasm.